Whole-exome sequencing reveals a likely pathogenic LMNA variant causing hypertrophic cardiomyopathy

Author:

Mahdavi Mohammad1,Mohsen-Pour Neda2,Maleki Majid3,Ghasemi Serwa1,Tabib Avisa4,Houshmand Golnaz1,Naderi Niloofar5,Masoumi Tannaz1,Pouraliakbar Hamidreza1,Kalayinia Samira5ORCID

Affiliation:

1. Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences , Tehran , Iran

2. Department of Genetics and Molecular Medicine, Zanjan University of Medical Sciences , Zanjan , Iran

3. Cardiogenetic Research Center and

4. Heart Valve Diseases Research Center, Iran University of Medical Sciences , Tehran , Iran

5. Cardiogenetic Research Center and Iran University of Medical Sciences , Tehran , Iran

Abstract

Abstract Objective We studied the clinical and molecular features of a family with hypertrophic cardiomyopathy (HCM). Background A very heterogeneous disease affecting the heart muscle, HCM is mostly caused by variants in the proteins of sarcomeres. The detection of HCM pathogenic variants can affect the handling of patients and their families. Methods Whole-exome sequencing (WES) was performed to assess the genetic cause(s) of HCM in a consanguineous Iranian family. Results Missense likely pathogenic variant c.1279C>T (p.Arg427Cys) within exon 7 of the LMNA gene (NM_170707) was found. The segregations were confirmed by polymerase chain reaction–based Sanger sequencing. Conclusions Variant c.1279C>T (p.Arg427Cys) in the LMNA gene seemed to have been the cause of HCM in the family. A few LMNA gene variants related to HCM phenotypes have been recognized so far. Identifying HCM genetic basis confers significant opportunities to understand how the disease can develop and, by extension, how this progression can be arrested. Our study supports WES effectiveness for first-tier variant screening of HCM in a clinical setting.

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Reference71 articles.

1. New perspectives on the prevalence of hypertrophic cardiomyopathy;Semsarian;. J Am Coll Cardiol,2015

2. Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States;Maron;Am J Cardiol,2016

3. Hypertrophic cardiomyopathy: past, present… and future;Bonow,2014

4. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine;Maron,2014

5. Hospital facilities at home for heart failure patients;Khaleghparast;Iran Heart J,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3